Price Alert

Reviva Pharmaceuticals I... (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.46

-0.05 (-10.63%)

At close: Aug 27, 2025, 3:59 PM

Reviva Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	10.36M	5.29M	13.48M	5.56M	6.18M	11.97M	23.37M	4.97M	11.15M	11.26M	18.52M	23.19M	19.42M	23.42M	29.69M	33.49M	35.8M	5.64M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	819.72K	819.72K	819.72K	819.72K	819.72K	n/a	n/a	n/a	n/a	n/a	403.82M	n/a	n/a	n/a	1.72M	n/a	n/a	1.82K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	346.96K	756.07K	666.43K	n/a	525.83K	743.38K	332.93K	414.74K	690.44K	1.65M	403.82K	849.02K	1.22M	1.85M	1.72M	402.32K	733.93K	1.01M
Total Current Assets	10.82M	6.26M	14.68M	6.81M	7.23M	13.5M	23.7M	5.39M	11.84M	12.9M	18.92M	24.04M	20.64M	25.27M	31.4M	33.89M	36.53M	6.66M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	819.72K	819.72K	819.72K	819.72K	819.72K	n/a	n/a	n/a	n/a	n/a	403.82M	n/a	n/a	n/a	1.72M	n/a	n/a	1.82K
Total Assets	11.63M	7.08M	15.5M	7.63M	8.05M	13.5M	23.7M	5.39M	11.84M	12.9M	18.92M	24.04M	20.64M	25.27M	31.4M	33.89M	36.53M	6.66M
Account Payables	4.97M	4.72M	6.28M	8.78M	4.69M	5.72M	3.85M	5.28M	2.65M	2.86M	3.52M	2.35M	2.55M	1.43M	509.58K	420.78K	358.26K	471.3K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	113.25K	224.3K	458.15K	83K	207.5K	332K	n/a	222.5K	222.5K	667.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	602.59K	556.88K	635.59K	428.8K	445.37K	377.37K	400.49K	7.53M	6.34M	3.03M	2.52M	1.23M	1.92M	2.2M	1.84M	552.92K	804.49K	630.04K
Total Current Liabilities	12.08M	11.51M	14.6M	17.53M	13.94M	14.49M	17.18M	13.03M	9.21M	6.56M	6.04M	3.58M	4.48M	3.62M	2.34M	973.7K	1.16M	1.1M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	16.69K	27.82K	89.01K	77.88K	150.21K	350.48K	806.65K	n/a	1.01M	556.31K	567.44K	105.7K	105.7K	283.72K	372.73K	650.89K	851.16K	1.04M
Total Long-Term Liabilities	16.69K	27.82K	89.01K	77.88K	150.21K	350.48K	806.65K	873.41K	1.01M	556.31K	567.44K	105.7K	105.7K	283.72K	372.73K	650.89K	851.16K	1.04M
Total Liabilities	12.09M	11.54M	14.69M	17.61M	14.09M	14.84M	17.98M	13.91M	10.22M	7.12M	6.61M	3.68M	4.58M	3.91M	2.72M	1.62M	2.01M	2.14M
Total Debt	113.25K	224.3K	458.15K	83K	207.5K	332K	n/a	222.5K	222.5K	667.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	6.8K	4.67K	4.66K	3.34K	2.98K	2.79K	2.79K	2.27K	2.27K	2.04K	2.04K	2.04K	1.51K	1.51K	1.44K	1.34K	1.34K	923.00
Retained Earnings	-176.76M	-170.71M	-164.27M	-158.01M	-149.65M	-141.79M	-134.35M	-120.71M	-110.22M	-97.77M	-91.17M	-83.05M	-79.54M	-74.2M	-66.83M	-63.15M	-60.87M	-59.26M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-459.15K	-4.46M	812.57K	-9.98M	-6.04M	-1.35M	5.72M	-8.52M	1.62M	5.78M	12.32M	20.36M	16.06M	21.36M	28.69M	32.27M	34.52M	4.52M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a